labetalol has been researched along with cyclic gmp in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasucci, DJ; Medakovic, M; Winer, N | 1 |
| D'Ascenzo, G; Gennari, C; Maioli, E; Nami, R; Nardi, PL; Pizzuti, M | 1 |
| Blaschke, TF; Haefeli, WE; Hoffman, BB; Kongpatanakul, S; Srivastava, N | 1 |
1 trial(s) available for labetalol and cyclic gmp
| Article | Year |
|---|---|
Comparison of intravenous dilevalol with placebo in moderate hypertension.
Topics: Aldosterone; Atrial Natriuretic Factor; Catecholamines; Cyclic GMP; Double-Blind Method; Humans; Hypertension; Injections, Intravenous; Labetalol; Male; Middle Aged; Placebos; Random Allocation; Renin | 1989 |
2 other study(ies) available for labetalol and cyclic gmp
| Article | Year |
|---|---|
[Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
Topics: Adrenergic beta-Antagonists; Adult; Cyclic AMP; Cyclic GMP; Ethanolamines; Female; Humans; Hypertension; Isoproterenol; Labetalol; Male; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sympathetic Nervous System | 1980 |
Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans.
Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hand; Humans; Labetalol; Male; Methylene Blue; Nitric Oxide; Skin; Vasoconstriction; Veins | 1993 |